| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |